Real Fusion, UAB - financials and debts

Company age: 6 y. 3 mo.

Update

Real Fusion - Company finances

EUR
2020
From: 2020-06-16
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 490,682 1,778,103 1,696,586 4,308,891 1,325,792 2,480,824
Profit before tax 33,176 233,565 306,141 244,974 - 194,227
Net profit 28,154 198,277 259,634 206,724 -7,964 157,907
Equity 30,654 228,931 488,565 695,290 87,326 245,233
Liabilities 358,916 772,589 629,083 735,260 561,016 722,608
Non-current assets 29,560 174,514 198,370 222,108 139,293 88,645
Current assets 359,613 825,914 917,486 1,204,906 510,453 1,037,961
Total assets 389,173 1,000,428 1,115,856 1,427,014 649,746 1,126,606
Taxes paid
STI taxes - - - 632,660 352,406 359,822
Social insurance contributions - - - 63,031 71,025 67,777
Financial indicators
Revenue change y/y - +262.4% -4.6% +154.0% -69.2% +87.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.2% 19.8% 23.3% 14.5% -1.2% 14.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 91.8% 86.6% 53.1% 29.7% -9.1% 64.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 5.7% 11.2% 15.3% 4.8% -0.6% 6.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 6.8% 13.1% 18.0% 5.7% - 7.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 11.7 3.4 1.3 1.1 6.4 2.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 137,392 381,019 328,369 820,741 279,114 561,692

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Real Fusion - Social security debts

From To Debt, €
2026-07-23 2026-07-26 12.09
2026-05-17 2026-05-24 5597.17
2026-01-22 2026-02-11 0.57

Real Fusion - VMI tax arrears

From To Overdue, €
2026-07-03 2026-07-07 1161.44
2026-06-30 2026-07-02 353.85
2026-06-28 2026-06-29 353.45
2026-04-10 2026-04-13 462.6
2026-04-09 2026-04-09 445.99
2025-08-24 2025-08-25 114.05
2025-08-23 2025-08-23 69.4
2025-07-28 2025-08-19 43110.56
2024-12-30 2024-12-30 3878.72
2024-10-12 2024-10-15 22.57

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Real Fusion, UAB (code 305575214) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.48M and net profit of €157.9K, corresponding to a profit margin of 6.4%. This followed a strong recovery from 2024, when revenue fell to €1.33M and the company posted a net loss of €8.0K, after a much stronger 2023 performance of €4.31M revenue and €206.7K net profit. Over the latest two years, revenue remains below the 2023 level, but the 2025 result shows a clear rebound. The balance sheet also improved in 2025, with total assets of €1.13M, equity of €245.2K and liabilities of €722.6K. Compared with 2024, equity strengthened while liabilities increased. Key indicators for 2025 show ROE of 64.4%, ROA of 14.0%, debt-to-equity of 2.95, and asset turnover of 2.20x. Revenue per employee was €620.2K and profit per employee €39.5K, indicating high operating productivity.